Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed…
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchits Concurrent Financing
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd.…
Indian Investment into UK At an All Time High
Grant Thornton's India Meets Britain Tracker 2025 to be unveiled at IGF…
FOBI AI Inc. Announces Closing of the Sale of German Subsidiary
June 12, 2025 16:53 ET | Source: Fobi AI Inc. Vancouver, BC,…
LANZAJET EXPANDS PARTNERSHIP WITH MICROSOFT TO STRENGTHEN THE COMPANY’S GLOBAL GROWTH
This agreement deepens multi-level collaboration with Microsoft across climate investment, renewable fuel…
Hycroft Announces Public Offering of Units
WINNEMUCCA, Nev., June 11, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq:…
Driving Clean Energy Forward: SANY R.E. Marks Milestone in Europe with Serbia’s Alibunar Wind Power Project
BEIJING, June 10, 2025 /PRNewswire/ -- As the global spotlight turns once…
TOPPAN Security Strengthens Market Leadership in Asia with Acquisition of dzcard Group
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- TOPPAN Security, a global leader…
HeartCore Signs 15th Go IPO Contract
June 03, 2025 16:30 ET | Source: HeartCore Enterprises Inc. NEW YORK…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…